Submit your email to push it up the queue
Sanofi Pasteur MSD GmbH, a prominent player in the biopharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 1994, the company has established itself as a leader in the development and distribution of vaccines, focusing on innovative solutions to prevent infectious diseases. With a diverse portfolio that includes vaccines for influenza, meningitis, and HPV, Sanofi Pasteur MSD is renowned for its commitment to public health and safety. The company’s unique approach combines cutting-edge research with a strong emphasis on quality, ensuring that their products meet the highest standards. Recognised for its significant contributions to vaccination programmes, Sanofi Pasteur MSD GmbH continues to strengthen its market position through strategic partnerships and a dedication to advancing immunisation efforts across the continent.
How does Sanofi Pasteur MSD GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sanofi Pasteur MSD GmbH's score of 69 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sanofi Pasteur MSD GmbH, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year. The company is a current subsidiary of Merck & Co., Inc., which influences its climate commitments and initiatives. While there are no documented reduction targets or specific emissions figures available, Sanofi Pasteur MSD GmbH's climate strategy is aligned with the broader initiatives of its parent company, Merck & Co., Inc. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which aim to enhance transparency and accountability in corporate climate action. As a subsidiary, Sanofi Pasteur MSD GmbH benefits from the sustainability frameworks and targets set by Merck & Co., Inc., which are cascaded down through the corporate structure. This relationship underscores the importance of collaborative efforts in addressing climate change within the pharmaceutical industry. In summary, while specific emissions data and reduction targets for Sanofi Pasteur MSD GmbH are not available, the company is positioned within a corporate family that prioritises climate action and sustainability through established initiatives from its parent organisation.
Access structured emissions data, company-specific emission factors, and source documents
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 5,760,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sanofi Pasteur MSD GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.